42 U.S.C. § 285c–2: Division Directors for…

§285c–2 Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; Functions

Title 42 › CHAPTER 6A — PUBLIC HEALTH SERVICE › SUBCHAPTER III — NATIONAL RESEARCH INSTITUTES › Part C — Specific Provisions Respecting National Research Institutes › subpart 3 — national institute of diabetes and digestive and kidney diseases › § 285c–2

Last updated Aug 21, 2026|Official source

Summary

Sets up three Division Directors in the Institute: one for Diabetes, Endocrinology, and Metabolic Diseases; one for Digestive Diseases and Nutrition; and one for Kidney, Urologic, and Hematologic Diseases. Under the Institute Director, they must make coordinated plans for NIH institutes about research and training in those disease areas; check and improve how those activities are managed; track and review spending; and find research opportunities and suggest how to use them. The Institute Director must send those plans and reviews to the NIH Director with any comments. Through these Division Directors, the Institute must fund and support research and training (except training paid for by Ruth L. Kirschstein National Research Service Awards) on diagnosing, preventing, and treating the listed diseases. That includes support for medical school and graduate clinical training, epidemiology studies, clinical trials, and interdisciplinary research. The Institute must also run programs to evaluate work, plan next steps, and share what is learned.

Title 42, §285c–2

The Public Health and Welfare, Source: USLM XML via OLRC

(a)(1)In the Institute there shall be a Division Director for Diabetes, Endocrinology, and Metabolic Diseases, a Division Director for Digestive Diseases and Nutrition, and a Division Director for Kidney, Urologic, and Hematologic Diseases. Such Division Directors, under the supervision of the Director of the Institute, shall be responsible for—

(A)developing a coordinated plan (including recommendations for expenditures) for each of the national research institutes within the National Institutes of Health with respect to research and training concerning diabetes, endocrine and metabolic diseases, digestive diseases and nutrition, and kidney, urologic, and hematologic diseases;

(B)assessing the adequacy of management approaches for the activities within such institutes concerning such diseases and nutrition and developing improved approaches if needed;

(C)monitoring and reviewing expenditures by such institutes concerning such diseases and nutrition; and

(D)identifying research opportunities concerning such diseases and nutrition and recommending ways to utilize such opportunities.

(2)The Director of the Institute shall transmit to the Director of NIH the plans, recommendations, and reviews of the Division Directors under subparagraphs (A) through (D) of paragraph (1) together with such comments and recommendations as the Director of the Institute determines appropriate.

(b)The Director of the Institute, acting through the Division Director for Diabetes, Endocrinology, and Metabolic Diseases, the Division Director for Digestive Diseases and Nutrition, and the Division Director for Kidney, Urologic, and Hematologic Diseases, shall—

(1)carry out programs of support for research and training (other than training for which Ruth L. Kirschstein National Research Service Awards may be made under section 288 of this title) in the diagnosis, prevention, and treatment of diabetes mellitus and endocrine and metabolic diseases, digestive diseases and nutritional disorders, and kidney, urologic, and hematologic diseases, including support for training in medical schools, graduate clinical training, graduate training in epidemiology, epidemiology studies, clinical trials, and interdisciplinary research programs; and

(2)establish programs of evaluation, planning, and dissemination of knowledge related to such research and training.

Notes & Related Subsidiaries

Editorial Notes

Amendments

2002—Subsec. (b)(1). Pub. L. 107–206 substituted “Ruth L. Kirschstein National Research Service Awards” for “National Research Service Awards”. 1993—Subsec. (b). Pub. L. 103–43 substituted “the” for “the the” before “Division Director for Diabetes” in introductory provisions.